Wormadole 400mg Tablet

Wormadole 400mg Tablet

S4
PDF Leaflet Revision Date: 22 August 2025

API: Albendazole | Company: Shanur Healthcare

Clinical Summary

Quick overview from the medicine insert

Indication

Indicated for various cancers including breast, lung, ovarian, prostate, and head and neck cancers.

Dosage (summary)

Administered as an IV infusion; typical dose is 75-100 mg/mu00b2 every 3 weeks depending on cancer type.

Onset of Action / Duration

Onset: 30 mins, Duration: 6-8 hours

Special Populations

  • Hepatic impairment
  • Elderly
  • Renal impairment

Pregnancy & Breastfeeding

Contraindicated in pregnancy and lactation due to teratogenic effects.

Key Drug Interactions

  • CYP3A4 inhibitors
  • Doxorubicin
  • Cisplatin

Contraindications

  • Hypersensitivity to docetaxel
  • Neutrophil count < 1500 cells/mmu00b3
  • Severe liver impairment

Common side effects

  • Neutropenia
  • Alopecia
  • Nausea
  • Vomiting
  • Stomatitis

Counselling Points

  • Monitor for signs of infection
  • Avoid pregnancy during treatment
  • Hydration and anti-emetics may be necessary

Serious warnings

  • Severe hypersensitivity reactions
  • Fluid retention
  • Increased risk of infection

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Wormadole 400mg Tablet
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW